UPDATE: Morgan Stanley Reiterates On Theravance As Slow Trends Weigh On Value
July 21, 2014 at 11:09 AM EDT
In a report published Monday, Morgan Stanley analyst David Friedman reiterated an Underweight rating on Theravance (NASDAQ: THRX), but ...